New Treatment for Late-Stage Pancreatic Cancer

Monday, 09 Sep 2013 11:00 AM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
U.S. Food and Drug Administration approval for Abraxane (paclitaxel) has been expanded to include advanced pancreatic cancer, the agency said.

The agency previously approved the chemotherapy drug to treat cancers of the lung and breast.

Some 45,220 people are expected to be diagnosed with pancreatic cancer this year, and an estimated 38,460 will die from it.
 
Pancreatic cancer is the fourth-leading cause of cancer death. Surgery is the only way to permanently remove pancreatic cancer, but it's usually too late for surgery by the time most cases are identified.

Abraxane's safety and effectiveness in treating pancreatic cancer were evaluated in clinical trials involving 861 people. Those treated with Abraxane and another chemotherapy drug, gemcitabine, lived an average of 1.8 months longer than those treated with gemcitabine alone.
 
Common side effects of the drug combination included a drop in white blood cells and blood platelets, fatigue, nerve damage in the extremities, vomiting, diarrhea and fever.
Abraxane is marketed by Celgene, based in Summit, N.J.

© HealthDay

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Two 'Breakthrough' Drugs for Lung Disease

Thursday, 16 Oct 2014 12:40 PM

Roche Holding AG (ROG) and Boehringer Ingelheim GmbH won approval for the first therapies in the U.S. to treat the deadl . . .

Drug Fights Chemo Nausea

Tuesday, 14 Oct 2014 12:24 PM

The combination drug Akynzeo (netupitant and palonosetron) has been approved by the U.S. Food and Drug Administration to . . .

Drug-Coated Catheter Clears Blocked Leg Arteries

Tuesday, 14 Oct 2014 12:20 PM

The first drug-coated balloon catheter designed to clear narrowed or blocked arteries in the thigh and knee has been app . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved